Shilpa Medicare Ratios

Shilpa Medicare Ltd Ratios

The Shilpa Medicare Ltd Ratios page provides a complete fundamental analysis of Shilpa Medicare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Shilpa Medicare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Shilpa Medicare Ltd (NSE: SHILPAMED, BSE: 530549) is currently trading at ₹336.65, with a market capitalization of ₹65.77B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Shilpa Medicare Ltd remains a key stock for fundamental analysis using Shilpa Medicare Ltd Ratios.

Shilpa Medicare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Shilpa Medicare Ltd P/E ratio currently stands at 82.51, making it one of the most tracked metrics in Shilpa Medicare Ltd Ratios.

Historically, the Shilpa Medicare Ltd P/E ratio has shown strong fluctuations:

• 2024: 82.51
• 2023: 125.64
• 2022: 0
• 2021: 56.83
• 2020: 18.41

The decline in Shilpa Medicare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Shilpa Medicare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.73.

Historical P/B trend:

• 2024: 2.73
• 2023: 2.21
• 2022: 1.12
• 2021: 1.89

Shilpa Medicare Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Shilpa Medicare Ltd P/S ratio currently stands at 5.03, an important part of Shilpa Medicare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 5.03
• 2023: 3.48
• 2022: 1.91
• 2021: 3.02

The rising Shilpa Medicare Ltd P/S ratio indicates improved revenue valuation by investors.

Shilpa Medicare Ltd Price to Cash Flow Ratio (P/CF)

The Shilpa Medicare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 101.72.

Historical Shilpa Medicare Ltd Price to Cash Flow Ratio:

• 2024: 101.72
• 2023: 87.66
• 2022: 16.08
• 2021: 51.63
• 2020: 98.92

The rising Shilpa Medicare Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Shilpa Medicare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Shilpa Medicare Ltd EV currently stands at ₹70.1B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 70.1B
• 2023: 49.01B
• 2022: 27.58B
• 2021: 40.85B

Shilpa Medicare Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Shilpa Medicare Ltd EV/EBITDA ratio is currently 22.74, a key metric in Shilpa Medicare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 22.74
• 2023: 20.60
• 2022: 32.13
• 2021: 20.73

Higher Shilpa Medicare Ltd EV/EBITDA suggests premium valuation.

Shilpa Medicare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Shilpa Medicare Ltd D/E ratio is currently 0.25, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.25
• 2023: 0.52
• 2022: 0.45
• 2021: 0.37

Shilpa Medicare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Shilpa Medicare Ltd ROE currently stands at 3.75%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 3.75
• 2023: 1.77
• 2022: -1.80
• 2021: 3.68

Declining ROE indicates pressure on profitability.

Shilpa Medicare Ltd Ratios Analysis Summary

The Shilpa Medicare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Shilpa Medicare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Shilpa Medicare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.